Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy
NCT ID: NCT03192904
Last Updated: 2021-08-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
70 participants
INTERVENTIONAL
2017-06-01
2018-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
NCT05711043
Gastrectomy at Low Pressure Trial - (GALPT)
NCT07313930
Use of Adjustable Gastric Band in Adolescents
NCT01882049
Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease
NCT05495139
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
NCT01564732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators set incidence rate of postoperative complications as their primary endpoint. According to their calculation, a total of 136 patients will be enrolled (each group has 68 patients).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Energy Instruments Group
All enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use energy instruments dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.
Energy Instruments
Energy Instruments, including electrocautery, harmonic scalpel and LigaSure.
Stapling Device Group
All enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use stapling device to dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.
Stapling Device
Stapling Device, including linear stapler and curved stapler.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Energy Instruments
Energy Instruments, including electrocautery, harmonic scalpel and LigaSure.
Stapling Device
Stapling Device, including linear stapler and curved stapler.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Poor pulmonary reserve or other major comorbidity that contraindicates lobectomy;
2. Peripheral nodule ≤2 cm with at least one of the following:
<!-- -->
1. Pure (Adenocarcinoma in situ) AIS histology;
2. Nodule has ≥50% ground-glass appearance on CT;
3. Radiologic surveillance confirms a long doubling time (≥400 days). 3. Normal in preoperative tests, such as blood routine examination, liver function, renal function, coagulation function, etc.
4\. ASA score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent.
Exclusion Criteria
2\. Patients have comorbidities in cardiovascular, kidney, lung or hematopoietic system, who cannot tolerate the surgery.
3\. Psychiatric patients。 4. Patient have history of chest trauma or surgery on ipsilateral chest.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hecheng Li M.D., Ph.D
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hecheng Li, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital
Xingshi Chen, MD
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RTS-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.